Soy germ extract alleviates menopausal hot flushes: placebo-controlled double-blind trial

• Published in: European journal of clinical nutrition Vol. 72; no. 7; pp. 961 - 970
• Main Authors: Imhof, Martin, Gocan, Anca, Imhof, Marianne, Schmidt, Mathias
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 01.07.2018; Nature Publishing Group
• Subjects: 692/699/2743; 692/700/2814; Aged; Clinical Nutrition; Diaries; Double-Blind Method; Double-blind studies; Epidemiology; Female; Glycine max - chemistry; Glycosides; Glycosides - pharmacology; Glycosides - therapeutic use; Hot Flashes - drug therapy; Humans; Internal Medicine; Isoflavones; Isoflavones - pharmacology; Isoflavones - therapeutic use; Medicine; Medicine & Public Health; Menopause; Metabolic Diseases; Middle Aged; Parameters; Phytotherapy; Plant Extracts - pharmacology; Plant Extracts - therapeutic use; Postmenopause; Public Health; Safety; Seeds; Soy products; Subgroups; Sweating; Treatment Outcome
• ISSN: 0954-3007; 1476-5640
• DOI: 10.1038/s41430-018-0173-3

Background/objectives A double-blind, placebo-controlled study was performed to assess the potency of a soy germ preparation for the alleviation of menopausal hot flushes. Subjects/methods Caucasian women with at least seven hot flushes daily were treated with soy germ extract (100 mg isoflavone glycosides) daily or with placebo for 12 weeks, followed by 12 weeks of open treatment with soy. Outcome parameters were the number of hot flushes and the evaluation of the Greene Climacteric Scale. Results A total of 192 women were included. As the hot flush diaries from one study centre were lost, the assessment of hot flushes was based on 136 participants (soy: 54 women; placebo: 82 women). After 12 weeks, 180 women were available for the analysis of Greene Scale and safety (soy and placebo: each 90 women). Hot flushes were reduced by 43.3% (–3.5 hot flushes) with soy and by 30.8% with placebo (–2.6; p  < 0.001). After the open treatment phase with soy, both original groups showed a reduction of 68% of hot flushes. A subgroup analysis showed better effects for soy when symptoms were classified as “severe” at baseline. After 12 weeks of double-blind treatment, there was an improvement from baseline values of 71 and 78% with soy with the items “hot flushes” and “sweating”, compared with 24% for both items with placebo. Hormonal safety parameters remained uninfluenced. Conclusions Soy germ extract with 100 mg of isoflavone glycosides was shown to modestly, but significantly reduce menopausal hot flushes.